Basal core-promoter mutant of hepatitis B virus and progression of liver disese in hepatitis B e antigen-negative chronic hepatitis B

被引:62
作者
Lin, CL
Liao, LY
Wang, CS
Chen, PJ
Lai, MY
Chen, DS
Kao, JH
机构
[1] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Taipei Municipal Jen Ai Hosp, Dept Gastroenterol, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[6] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan
[7] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Taipei, Taiwan
关键词
basal core promoter; chronic hepatitis B; hepatitis B genotype; hepatitis B virus mutant; hepatitis e antigen; hepatocellular carcinoma; liver cirrhosis;
D O I
10.1111/j.1478-3231.2005.01041.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The long-term outcomes in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B are distinct from those in HBeAg-positive chronic hepatitis. However, the molecular virological factors that contribute to the progression of liver disease in this special clinical setting remain largely unknown. We thus investigated the association of hepatitis B virus (HBV) genotypes as well as precore/basal core-promoter mutations with the clinical and virological characteristics of patients with HBeAg-negative chronic hepatitis B in Taiwan. Methods: HBV genotypes and sequences of precore and basal core-promoter regions of the HBV genome were determined in 174 HBeAg-negative chronic HBV infection patients including 62 inactive carriers and 112 with different stages of liver disease. Results: HBV carriers with older age (> 50 years) (odds ratio, 9.09; 95% confidence interval (CI), 3.22-25, P < 0.001) and basal core-promoter mutant of HBV (odds ratio, 4.12; 95% Cl, 1.41-12.03, P = 0.01) were associated with the development of liver cirrhosis and hepatocellular carcinoma (HCC). The gender-related risk factors associated with the development of liver cirrhosis and HCC were further analyzed, and basal core-promoter mutant was only associated with the development of liver cirrhosis and HCC in male carriers (odds ratio, 4.35; 95% CI, 1.30-14.52, P = 0.02). Conclusions: The risk of development of liver cirrhosis and HCC is significantly increased in patients with advanced age as well as with basal core-promoter mutant of HBV. In addition, basal core-promoter mutant might contribute to the gender difference of the progression of liver disease in HBeAg-negative chronic hepatitis B in Taiwan.
引用
收藏
页码:564 / 570
页数:7
相关论文
共 36 条
[1]   Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study [J].
Brunetto, MR ;
Oliveri, F ;
Coco, B ;
Leandro, G ;
Colombatto, P ;
Gorin, JM ;
Bonino, F .
JOURNAL OF HEPATOLOGY, 2002, 36 (02) :263-270
[2]   A NEW HEPATITIS-B VIRUS-STRAIN IN PATIENTS WITH SEVERE ANTI-HBE POSITIVE CHRONIC HEPATITIS-B [J].
BRUNETTO, MR ;
STEMLER, M ;
BONINO, F ;
SCHODEL, F ;
OLIVERI, F ;
RIZZETTO, M ;
VERME, G ;
WILL, H .
JOURNAL OF HEPATOLOGY, 1990, 10 (02) :258-261
[3]  
CARMAN WF, 1989, LANCET, V2, P588
[4]   Epidemiological characteristics and risk factors of hepatocellular carcinoma [J].
Chen, CJ ;
Yu, MW ;
Liaw, YF .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (9-10) :S294-S308
[5]   Epidemiology of hepatitis B virus infection in the Asia-Pacific region [J].
Chen, CJ ;
Wang, LY ;
Yu, MW .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 :E3-E6
[6]   Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C [J].
Chu, CJ ;
Hussain, M ;
Lok, ASF .
GASTROENTEROLOGY, 2002, 122 (07) :1756-1762
[7]   NATURAL-HISTORY OF CHRONIC HEPATITIS-B VIRUS-INFECTION IN TAIWAN - STUDIES OF HEPATITIS-B VIRUS-DNA IN SERUM [J].
CHU, CM ;
KARAYIANNIS, P ;
FOWLER, MJF ;
MONJARDINO, J ;
LIAW, YF ;
THOMAS, HC .
HEPATOLOGY, 1985, 5 (03) :431-434
[8]   Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China [J].
Ding, X ;
Mizokami, M ;
Yao, GB ;
Xu, B ;
Orito, E ;
Ueda, R ;
Nakanishi, M .
INTERVIROLOGY, 2001, 44 (01) :43-47
[9]  
Fujie H, 2001, GASTROENTEROLOGY, V120, P1564, DOI 10.1053/gast.2001.24501
[10]   T-cell mediated immune responses in patients with hepatitis B e antigen negative chronic hepatitis B. [J].
Vassilopoulos, D ;
Rapti, I ;
Nikolaou, M ;
Hadziyannis, SJ .
HEPATOLOGY, 2001, 34 (04) :315A-315A